GDTC
Price
$2.22
Change
-$0.05 (-2.20%)
Updated
Nov 13 closing price
13 days until earnings call
RXRX
Price
$7.32
Change
-$0.26 (-3.43%)
Updated
Nov 13 closing price
110 days until earnings call
Ad is loading...

GDTC vs RXRX

Header iconGDTC vs RXRX Comparison
Open Charts GDTC vs RXRXBanner chart's image
CytoMed Therapeutics
Price$2.22
Change-$0.05 (-2.20%)
Volume$6.15K
CapitalizationN/A
Recursion Pharmaceuticals
Price$7.32
Change-$0.26 (-3.43%)
Volume$6.59M
CapitalizationN/A
GDTC vs RXRX Comparison Chart
Loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GDTC vs. RXRX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GDTC is a Buy and RXRX is a StrongSell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (GDTC: $2.22 vs. RXRX: $7.31)
Brand notoriety: GDTC and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GDTC: 42% vs. RXRX: 134%
Market capitalization -- GDTC: $26.17M vs. RXRX: $2.1B
GDTC [@Biotechnology] is valued at $26.17M. RXRX’s [@Biotechnology] market capitalization is $2.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GDTC’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • GDTC’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both GDTC and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXRX’s TA Score shows that 6 TA indicator(s) are bullish.

  • RXRX’s TA Score: 6 bullish, 4 bearish.

Price Growth

GDTC (@Biotechnology) experienced а -9.02% price change this week, while RXRX (@Biotechnology) price change was +4.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

GDTC is expected to report earnings on May 05, 2025.

RXRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.1B) has a higher market cap than GDTC($26.2M). RXRX YTD gains are higher at: -25.862 vs. GDTC (-54.694).
GDTCRXRXGDTC / RXRX
Capitalization26.2M2.1B1%
EBITDAN/A-348.35M-
Gain YTD-54.694-25.862211%
P/E RatioN/AN/A-
RevenueN/A48.6M-
Total CashN/A474M-
Total DebtN/A89.9M-
TECHNICAL ANALYSIS
Technical Analysis
RXRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEIYX38.280.02
+0.05%
Putnam Large Cap Value Y
PWGIX28.940.01
+0.03%
Impax US Sustainable Economy Instl
OAKWX22.80-0.10
-0.44%
Oakmark Global Select Investor
GLNCX20.66-0.10
-0.48%
MFS Global New Discovery C
PSGRX74.43-0.99
-1.31%
Putnam Small Cap Growth R

GDTC and

Correlation & Price change

A.I.dvisor tells us that GDTC and CVKD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GDTC and CVKD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
-2.09%
CVKD - GDTC
29%
Poorly correlated
-6.60%
ADIL - GDTC
27%
Poorly correlated
-2.84%
TENX - GDTC
25%
Poorly correlated
-3.06%
RXRX - GDTC
23%
Poorly correlated
-3.56%
NURPF - GDTC
21%
Poorly correlated
N/A
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with BEAM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-3.56%
BEAM - RXRX
61%
Loosely correlated
-1.57%
CRSP - RXRX
56%
Loosely correlated
-1.85%
EXAI - RXRX
55%
Loosely correlated
-3.61%
PRME - RXRX
54%
Loosely correlated
-8.33%
NTLA - RXRX
52%
Loosely correlated
-3.24%
More